Перейти к содержанию

Illumina, Inc. (ILMN) stock: revenue, earnings & dividend

Illumina, Inc. (ILMN, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener ILMN · Nasdaq Medizintechnik & Messgeräte US-CA

Key figures

Fiscal year
2025
Revenue
4.34 bn $
Revenue growth
-0.7 %
Revenue growth 5y (p.a.)
6 %
Net income
850 m $
Net margin
19.6 %
Operating margin
18.6 %
Earnings per share (diluted)
5.45 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
6.64 bn $
Equity
2.72 bn $
Equity ratio
41 %
Return on equity
31.2 %
Cash
1.42 bn $
Operating cash flow
1.08 bn $
Free cash flow
931 m $
Shares outstanding
151,200,000

History

Revenue by fiscal year

2016 2.4 bn $
2017 2.75 bn $
2018 3.33 bn $
2019 3.54 bn $
2020 3.24 bn $
2021 4.53 bn $
2022 4.58 bn $
2023 4.5 bn $
2024 4.37 bn $
2025 4.34 bn $

Net income by fiscal year

2016 463 m $
2017 726 m $
2018 826 m $
2019 1 bn $
2020 656 m $
2021 762 m $
2022 -4.4 bn $
2023 -1.16 bn $
2024 -1.22 bn $
2025 850 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20254.34 bn $850 m $5.45 $–1.08 bn $
20244.37 bn $-1.22 bn $-7.69 $–837 m $
20234.5 bn $-1.16 bn $-7.34 $–478 m $
20224.58 bn $-4.4 bn $-28.00 $–392 m $
20214.53 bn $762 m $5.04 $–545 m $
20203.24 bn $656 m $4.45 $–1.08 bn $
20193.54 bn $1 bn $6.74 $–1.05 bn $
20183.33 bn $826 m $5.56 $–1.14 bn $
20172.75 bn $726 m $4.92 $–875 m $
20162.4 bn $463 m $3.07 $–779 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)